Lv4
410 积分 2024-01-17 加入
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
1天前
已完结
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
1天前
待确认
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease Onset Age With Risk of Incident Type 2 Diabetes
2天前
已完结
Differential associations of cardiometabolic risk factors with liver-related events by alcohol consumption category: Results from a large population-based study
2天前
已完结
One-Year Changes in Liver Stiffness Measurement, but Not in Alanine Aminotransferase and Controlled Attenuation Parameter, Predict Long-Term Liver Outcomes in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
2天前
已完结
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLD
3天前
已完结
Prior Use of GLP-1 Receptor Agonists versus SGLT2 Inhibitors and Clinical Outcomes After Sepsis in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study
3天前
已完结
Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes
4天前
已完结
Clinical outcomes of lean metabolic dysfunction-associated steatotic liver disease by phenotypic subtypes
4天前
已完结
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
4天前
已完结
皖公网安备34019202002308
